Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 03 Feb 2023

Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy

in Pharmacology of Anti-Cancer Drugs

Claudia Arndt
Antje Tunger
Rebekka Wehner
Rebecca Rothe
Eleni Kourtellari
Stephanie Luttosch
Katharina Hannemann
Stefanie Koristka
Liliana R. Loureiro
Anja Feldmann

Frontiers in Pharmacology

doi 10.3389/fphar.2023.970457

5,134 views
5 citations

Original Research

Published on 03 Feb 2023

Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia

in Pharmacology of Anti-Cancer Drugs

Yuan-Yuan Shi
Zeng-Yan Liu
Gui-Xin Zhang
Yi He
Ming-Zhe Han
Si-Zhou Feng
Rong-Li Zhang
Er-Lie Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1014306

3,012 views
1 citation

Case Report

Published on 03 Feb 2023

Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report

in Pharmacology of Anti-Cancer Drugs

Xuesong Chen
Wangjian Zha
Mei Su
Nan Meng
Shuliang Cao
Beifang Niu
Xu Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1053805

4,332 views
3 citations

Case Report

Published on 02 Feb 2023

Case report: Savolitinib induced severe adverse reactions resembling septic shock in an HIV-1–positive patient with advanced non-small cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Ye Xiong
Qing Cao
Yongzheng Guo
Xiang Liu
Xueling Zhu
Bohao Dai
Biao Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1089184

2,576 views
3 citations

Review

Published on 02 Feb 2023

LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials

in Pharmacology of Anti-Cancer Drugs

Beatrice Noce
Elisabetta Di Bello
Rossella Fioravanti
Antonello Mai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1120911

24,763 views
82 citations

Editorial

Published on 01 Feb 2023

Editorial: Targeting autophagy in Cancer Therapy: Focus on small-molecule modulators and new strategies

in Pharmacology of Anti-Cancer Drugs

Ryszard Pluta

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1145255

1,435 views
1 citation

Correction

Published on 31 Jan 2023

Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

in Pharmacology of Anti-Cancer Drugs

Minglu Liu
Tong Hu
Wenfeng Gou
Huajie Chang
Yanli Li
Yiliang Li
Daiying Zuo
Wenbin Hou
Shunchang Jiao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1140018

1,936 views

Review

Published on 30 Jan 2023

Recent advances in peptide-based therapeutic strategies for breast cancer treatment

in Pharmacology of Anti-Cancer Drugs

Ling Li
Gregory J. Duns
Wubliker Dessie
Zhenmin Cao
Xiaoyuan Ji
Xiaofang Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1052301

11,921 views
17 citations

Systematic Review

Published on 30 Jan 2023

Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis

in Pharmacology of Anti-Cancer Drugs

Xueqiong Xun
Jun Ai
Fuhui Feng
Pan Hong
Saroj Rai
Ruikang Liu
Baowen Zhang
Yeming Zhou
Huiyong Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1108772

4,302 views
2 citations

Review

Published on 26 Jan 2023

Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer

in Pharmacology of Anti-Cancer Drugs

Priya Mondal
Syed Musthapa Meeran

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1105484

4,612 views
18 citations

Original Research

Published on 25 Jan 2023

Development and optimization of nanoparticles loaded with erucin, a dietary isothiocyanate isolated from Eruca sativa: Antioxidant and antiproliferative activities in ehrlich-ascites carcinoma cell line

in Pharmacology of Anti-Cancer Drugs

Sharabjit Singh
Gurdeep Singh
Shivani Attri
Prabhjot Kaur
Farhana Rashid
Neena Bedi
Shafiul Haque
Essam M. Janahi
Saroj Arora

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1080977

4,316 views
6 citations

Original Research

Published on 25 Jan 2023

Transcription factor ZBTB42 is a novel prognostic factor associated with immune cell infiltration in glioma

in Pharmacology of Anti-Cancer Drugs

Yanwen Li
Yongwei Zhu
Long Chen
Shunjin Xia
Abraham Ayodeji Adegboro
Siyi Wanggou
Xuejun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1102277

2,914 views

Systematic Review

Published on 24 Jan 2023

Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Zijing Liu
Tiankai Xu
Pengyu Chang
Weijia Fu
Jiaying Wei
Chengcheng Xia
Qiang Wang
Man Li
Xiaoyu Pu
Fuxue Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1064227

5,883 views
8 citations

Review

Published on 23 Jan 2023

Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305

in Pharmacology of Anti-Cancer Drugs

Jingcao Zheng
Zhengyu Li
Wenjiao Min

Frontiers in Pharmacology

doi 10.3389/fphar.2022.979873

10,104 views
12 citations

Case Report

Published on 23 Jan 2023

Case Report: Clinical benefit from multi-target tyrosine kinase inhibitor and PARP inhibitor in a patient with cancer of unknown primary with BRCA1 large genomic rearrangement

in Pharmacology of Anti-Cancer Drugs

Ling Yu
Jietao Lin
Hanhan Li
Lingling Sun
Shubo Wang
Yaoxu Chen
Hanrui Chen
Lizhu Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.997760

1,732 views
1 citation

Original Research

Published on 23 Jan 2023

Leonurine promotes the maturation of healthy donors and multiple myeloma patients derived-dendritic cells via the regulation on arachidonic acid metabolism

in Pharmacology of Anti-Cancer Drugs

Cheng Chen
Lin He
Xi Wang
Rong Xiao
Shu Chen
Zichen Ye
Xuemei Wang
Yu Wang
Yizhun Zhu
Jingying Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1104403

2,699 views
5 citations